Egetis Therapeutics AB (EGTX) NPV

Sell:5.28 SEKBuy:5.30 SEK0.12 SEK (2.22%)

Prices delayed by at least 15 minutes
Sell:5.28 SEK
Buy:5.30 SEK
Change:0.12 SEK (2.22%)
Prices delayed by at least 15 minutes
Sell:5.28 SEK
Buy:5.30 SEK
Change:0.12 SEK (2.22%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
8 November 2024
Henrik KrookVice President
Buy
Regular purchase transaction
65,0004.31 SEK280,150.00 SEK404,593
8 November 2024
Christian SonessonVice President
Buy
Regular purchase transaction
3,0004.12 SEK12,360.00 SEK42,298
8 November 2024
Christian SonessonVice President
Buy
Regular purchase transaction
3,0004.22 SEK12,660.00 SEK39,298
7 October 2024
Yilmaz MahshidCFO
Buy
Regular purchase transaction
10,0004.23 SEK42,250.00 SEK313,089
7 October 2024
Nicklas WesterholmCEO
Buy
Regular purchase transaction
10,1424.25 SEK43,103.50 SEK242,718
23 February 2024
Nicklas WesterholmCEO
Buy
Regular purchase transaction
19,6006.10 SEK119,560.00 SEK232,576

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
8 November 2024
Henrik KrookVice President
Buy
Regular purchase transaction
65,0004.31 SEK280,150.00 SEK404,593
23 February 2024
Nicklas WesterholmCEO
Buy
Regular purchase transaction
19,6006.10 SEK119,560.00 SEK232,576
7 October 2024
Nicklas WesterholmCEO
Buy
Regular purchase transaction
10,1424.25 SEK43,103.50 SEK242,718
7 October 2024
Yilmaz MahshidCFO
Buy
Regular purchase transaction
10,0004.23 SEK42,250.00 SEK313,089
8 November 2024
Christian SonessonVice President
Buy
Regular purchase transaction
3,0004.22 SEK12,660.00 SEK39,298

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.